Core Viewpoint - Global Medical (02666.HK) has received approval from the China Securities Regulatory Commission to publicly issue a maximum of RMB 2 billion in domestic perpetual corporate bonds aimed at qualified investors, with a remaining quota of RMB 1.2 billion as of the announcement date [1] Group 1 - The bond issuance will be conducted in tranches, with the total principal amount for this issuance not exceeding RMB 850 million [1] - The basic term of the corporate bond is set at 3 years, with the issuer having the option to extend the term by one repricing cycle or fully redeem the bond at the end of the agreed term and each repricing cycle [1] - The bond includes options for the issuer to extend the term, defer interest payments, and redeem the bond [1] Group 2 - The interest rate for the first cycle will remain fixed and will be determined through a book-building process at the time of subscription, with the coupon rate set as the initial benchmark rate plus an initial spread [1] - Subsequent cycles will see the coupon rate adjusted to the current benchmark rate plus the initial spread plus an additional 300 basis points [1] - The net proceeds from this bond issuance will be used by the issuer to supplement operational funds [1]
环球医疗(02666.HK)附属公开发行2025年第二期可续期公司债券